BML Investment Partners, L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-13 4:11 pm Purchase | 2022-04-11 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 527,000 12.200% | 294,030 (+126.21%) | Filing |
| 2022-03-10 2:01 pm Unchanged | 2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 232,970 5.400% | 0 (Unchanged) | Filing |
| 2022-03-10 1:16 pm Purchase | 2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX | BML Investment Partners, L.P. | 232,970 5.400% | 232,970 (New Position) | Filing |